Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
- Gowtham A. Rao, MD, PhD, MPH1,2,3,4⇑,
- Joshua R. Mann, MD, MPH1,3,
- Azza Shoaibi, BPharm, MPH1,2,3,4,
- Charles Lee Bennett, MD, PhD, MPP2,3,4,
- Georges Nahhas, MPH3,
- S. Scott Sutton, PharmD2,4,
- Sony Jacob, MD2 and
- Scott M. Strayer, MD, MPH1
+ Author Affiliations
- CORRESPONDING AUTHOR: Gowtham A. Rao, MD, PhD, MPH, Department of Family and Preventive Medicine, School of Medicine, University of South Carolina, 3209 Colonial Dr, Columbia, SC 29203, gowtham.rao@va.gov
Abstract
PURPOSE Azithromycin
use has been associated with increased risk of death among patients at
high baseline risk, but not for younger
and middle-aged adults. The Food and Drug
Administration issued a public warning on azithromycin, including a
statement that
the risks were similar for levofloxacin. We
conducted a retrospective cohort study among US veterans to test the
hypothesis
that taking azithromycin or levofloxacin would
increase the risk of cardiovascular death and cardiac arrhythmia
compared with
persons taking amoxicillin.
METHODS We studied a
cohort of US veterans (mean age, 56.8 years) who received an exclusive
outpatient dispensation of either amoxicillin
(n = 979,380), azithromycin (n = 594,792), or
levofloxacin (n = 201,798) at the Department of Veterans Affairs between
September
1999 and April 2012. Azithromycin was dispensed
mostly for 5 days, whereas amoxicillin and levofloxacin were dispensed
mostly
for at least 10 days.
RESULTS During
treatment days 1 to 5, patients receiving azithromycin had significantly
increased risk of death (hazard ratio [HR]
= 1.48; 95% CI, 1.05–2.09) and serious
arrhythmia (HR = 1.77; 95% CI, 1.20–2.62) compared with patients
receiving amoxicillin.
On treatment days 6 to 10, risks were not
statistically different. Compared with patients receiving amoxicillin,
patients
receiving levofloxacin for days 1 to 5 had a
greater risk of death (HR = 2.49, 95% CI, 1.7–3.64) and serious cardiac
arrhythmia
(HR = 2.43, 95% CI, 1.56–3.79); this risk
remained significantly different for days 6 to 10 for both death (HR =
1.95, 95%
CI, 1.32–2.88) and arrhythmia (HR = 1.75; 95%
CI, 1.09–2.82).
CONCLUSIONS Compared
with amoxicillin, azithromycin resulted in a statistically significant
increase in mortality and arrhythmia risks
on days 1 to 5, but not 6 to 10. Levofloxacin,
which was predominantly dispensed for a minimum of 10 days, resulted in
an
increased risk throughout the 10-day period.
- Received for publication May 16, 2013.
- Revision received August 30, 2013.
- Accepted for publication September 12, 2013.
- © 2014 Annals of Family Medicine, Inc.
No comments:
Post a Comment